Active immunotherapy of multiple myeloma
Open Access
- 31 July 2006
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (11) , 1653-1660
- https://doi.org/10.1016/j.ejca.2006.03.008
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- In vivo peripheral expansion of naive CD4+CD25highFoxP3+ regulatory T cells in patients with multiple myelomaBlood, 2006
- CD8+T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burdenBlood, 2005
- Tumor antigen immunization of sibling stem cell transplant donors in multiple myelomaBone Marrow Transplantation, 2005
- NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responsesBlood, 2005
- Primary Antitumor Immune Response Mediated by CD4+ T CellsImmunity, 2005
- In vitroPriming of Myeloma Antigen-specific Allogeneic Donor T Cells with Idiotype Pulsed Dendritic CellsLeukemia & Lymphoma, 2003
- Idiotypic protein-pulsed dendritic cell vaccination in multiple myelomaInternational Journal of Cancer, 1999
- Molecular Cloning and Characterization of a Surface Antigen Preferentially Overexpressed on Multiple Myeloma CellsBiochemical and Biophysical Research Communications, 1999
- Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytomaEuropean Journal of Immunology, 1996
- Restricted α/β receptor gene usage of idiotype-specific major histocompatibility complex-restricted T cells: Selection for CDR3-related sequencesEuropean Journal of Immunology, 1992